News Related to Almirall

Related coverage linked through entity extraction aliases.

Lebrikizumab and Stapokibart Show Efficacy in Pediatric Atopic Dermatitis Trials

Mar 16, 2026

Two phase 3 trials demonstrate significant improvements in skin clearance and disease severity for children and adolescents with moderate-to-severe atopic dermatitis treated with targeted biologics.

Alopecia Areata Market Expected to Expand by 2036 with Novel Therapies in Development

Mar 04, 2026

The alopecia areata treatment market is projected to grow significantly through 2036, driven by rising prevalence and the anticipated launch of emerging therapies including JAK inhibitors and novel drug classes targeting immune pathways.